Market Place
Sourcing Support
All News #Library
Biotech
Acadia CEO, Peers Lobby vs. MFN Pricing for Small Biotechs
13 Jan 2026 //
BIOSPACE
Acadia Appoints Konstantina Katcheves as Senior VP for Business
26 Aug 2025 //
CONTRACTPHARMA
Acadia Introduces New Team and Pipeline for Biotech Goals
15 Jul 2025 //
BIOSPACE
Acadia Submits Marketing Application To EMA For Trofinetide
14 Jan 2025 //
BUSINESSWIRE
Acadia nabs rights to Saniona`s tremor asset in $582M biobucks deal
27 Nov 2024 //
FIERCE BIOTECH
Acadia Pharma Announces License Agreement with Saniona for SAN711
26 Nov 2024 //
BUSINESSWIRE
Acadia Announces Health Canada Approval Of Daybue For Rett Syndrome
16 Oct 2024 //
BUSINESSWIRE
Acadia`s Trofinetide NDS For Rett Accepted, Priority Review
22 Apr 2024 //
BUSINESSWIRE
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide
13 Jul 2023 //
BUSINESSWIRE
Acadia Pharmaceuticals to Present DAYBUE™ (trofinetide) Clinical Data
20 Apr 2023 //
BUSINESSWIRE
Acadia Pharma Announces DAYBUE™ (trofinetide) is Now Available
17 Apr 2023 //
BUSINESSWIRE
FDA accepts one, delays another; Data, deals and dollars for slate of biotechs
09 Jan 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.